PDF
ePub
Citation
Print
Soon Hee Shim1
, Jeong Hye Kim2
, Jeong Hye Kim2
Abstract
Purpose
The purpose of this study was to investigate the resilience and quality of life (QoL) of patients with non-Hodgkin lymphoma (NHL) and the factors influencing QoL.
Methods
A sample of 85 outpatients who had been diagnosed with NHL were included in a descriptive study. The instruments used were the Connor-Davidson Resilience Scale and Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym) version 4.
Results
The mean resilience score of the patients was 73.11±15.81 out of 100. The total mean QoL score was 130.23±20.70 out of 168, the highest category was physical well-being with a mean item score of 21.80±5.03, the lowest was emotional well-being with a mean item score of 19.28±3.95. Resilience and QoL were positively correlated (r=.65, p<.001). Regression analysis revealed that the QoL of the patients was explained by resilience, gender, and Eastern Cooperative Oncology Group performance status. These variables explained 53% of the variance of QoL.
Figures and Tables
References
1. National Cancer Center (KR). Korea Central Cancer Registry. Annual report of cancer statistics in Korean 2014 [Internet]. Accessed September 28, 2018. Available from: http://ncc.re.kr/cancerStatsView.ncc?bbsnum=397&searchKey=total&searchValue=&pageNum=1.
2. The Blood of Lymphoma Study Group. The correct understanding of lymphoma. Seoul: Korean Medicine;2017.
3. The Korean Society of Hematology. Malignant lymphoma [Internet]. Accessed January 10, 2019. Available from: http://www.hematology.or.kr/sub07/hematodyscrasia06.pdf.
4. Kim JH. A study on the development and application of the nursing program for cancer patients undergoing chemotherapy [master's thesis]. Seoul: Hanyang Univ.;2003.
5. Asan Medical Center. Understanding lymphoma [Internet]. Accessed January 10, 2019. Available from: http://cancer.amc.seoul.kr/asan/depts/cancer/K/content.do?menuId=3636.
6. Park MS, Kim KS. Cancer survivors’ life experience. J Korean Oncol Nurs. 2008; 8:93–104.
7. Thompson CA, Yost KJ, Maurer MJ, Allmer C, Farooq U, Habermann TM, et al. Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma. Hematol Oncol. 2018; 36:749–756.
8. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. J Clin Oncol. 2008; 26:1355–1363.
9. Sandler IN, Wolchik SA, Ayers TS. Resilience rather than recovery: a contextual framework on adaptation following bereavement. Death Stud. 2008; 32:59–73.
10. Choi UJ, Kim YS, Kang JS. Effect of uncertainty and resilience on stress for cancer patients. Korean J Stress Res. 2018; 26:250–256.
11. Jung SC. The relationship among resilience, stress and self care of cancer patients receiving chemotherapy [master's thesis]. Jinju: Gyeongsang National Univ.;2012.
12. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003; 18:76–82.
13. Webster K, Cella D. Quality of life in patients with low-grade non-Hodgkin’s lymphoma. Oncology (Williston Park). 1998; 12:697–714.
14. Kwak SY. The relationship between resilience and levels of family support, anxiety and depression in patients with hematologic malignancy [master's thesis]. Seoul: Ewha Womans Univ.;2012.
15. Kim JI, Byeon YS. A study on the factors affecting resilience in patients with colon cancer. Asian Oncol Nurs. 2013; 13:256–264.
16. Strauss B, Brix C, Fischer S, Leppert K, Füller J, Roehrig B, et al. The influence of resilience on fatigue in cancer patients undergoing radiation therapy (RT). J Cancer Res Clin Oncol. 2007; 133:511–518.
17. Lee EK. A study on factors affecting cancer patients. J Korean Acad Soc Nurs Educ. 2007; 13:52–58.
18. Choi KS, Park JA, Lee JH. The effect of symptom experience and resilience on quality of life in patients with colorectal cancers. Asian Oncol Nurs. 2012; 12:61–68.
19. Smith SK, Zimmerman S, Williams CS, Zebrack BJ. Health status and quality of life among non-Hodgkin lymphoma survivors. Cancer. 2009; 115:3312–3323.
20. Oh PJ. Predicting quality of life in people with cancer. J Nurs Acad Soc. 1997; 27:901–911.
21. Cappiello M, Cunningham RS, Knobf MT, Erdos D. Breast cancer survivors: information and support after treatment. Clin Nurs Res. 2007; 16:278–293.
22. Pettengell R, Donatti C, Hoskin P, Poynton C, Kettle PJ, Hancock B, et al. The impact of follicular lymphoma on health-related quality of life. Ann Oncol. 2008; 19:570–576.
23. Lee J, Kim M. Relationships among uncertainty, distress, and quality of life in lung cancer patients: mediating effect of resilience. J Muscle Joint Health. 2018; 25:148–156.
24. Park JA, Hong JY. Factors influencing quality of life in adult cancer patients: the Sixth Korea National Health and Nutrition Examination Survey (KNHANES VI-2), 2014. J Korea Acad Ind Coop Soc. 2017; 18:382–390.
25. Lee EJ, Yoon JH, Park D, Park D. Performance status and resilience in patients with colorectal cancer. Asian Oncol Nurs. 2013; 13:273–279.
26. Hong SK. Concept development of resilience - focusing on cancer patients -. J Korean Acad Soc Nurs Educ. 2009; 15:109–119.
27. Cella D, Webster K, Cashy J, Kutikova L, Burgess MF, Lin BK, et al. Development of a measure of health-related quality of life for non-Hodgkin’s lymphoma clinical research: the Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym). Blood. 2005; 106:750.
28. Yost KJ, Thompson CA, Eton DT, Allmer C, Ehlers SL, Habermann TM, et al. The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2013; 54:290–297.
XML Download